Clearing the path to lower cholesterol
This study is looking at an investigational medication for participants with, or at risk for, CVD, who are also statin intolerant. Approximately 12,000 people will take part in this study to help doctors determine whether the investigational medication can help to reduce the occurrence of major CVD events, such as heart attacks and strokes. The study will also look at how safe the investigational medication is.
You may be able to take part in the CLEAR Outcomes Study if you:
The study will last approximately 3.75 years and will require visits to the study centre and telephone calls with the study team.
All study-related medication and assessments will be provided at no cost.
If you would like to learn more about this study, please contact the study team via our application form.